Pharmaceutical

ESCMID 2024: Emerging bacterial infections in neonates and children

Coinfections can complicate disease management and hence continued surveillance and targeted intervention strategies are needed.

May 9, 2024 - 00:00
ESCMID 2024: Emerging bacterial infections in neonates and children
Coinfections can complicate disease management and hence continued surveillance and targeted intervention strategies are needed.
Read the original article

Tags:

Previous Article

Study led by ORNL informs climate resilience strategies in urban, rural areas

Next Article

Biotechs must prioritise ethics to deter GenAI “bad actors”

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Robotics Companies & Manufacturers for the Pharmaceutical Industry

Robotics Companies & Manufacturers for the Pharmaceutic...

Oct 2, 2024

Celiac study examines precisely how gluten triggers injury to intestine

Celiac study examines precisely how gluten triggers inj...

Jul 14, 2023

Atea secures Fast Track designation for Covid-19 drug bemnifosbuvir

Atea secures Fast Track designation for Covid-19 drug b...

Apr 26, 2023